CareDx Inc
CDNA
View Detailed Chart
19.450USD
+0.260+1.35%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
999.87MMarket Cap
14.42P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
+1.35%
5 Days
-5.40%
1 Month
+21.71%
6 Months
+2.21%
Year to Date
-9.15%
1 Year
-5.35%
View Detailed Chart
TradingKey Stock Score of CareDx Inc
Currency: USD Updated: 2025-12-19Key Insights
CareDx Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 6/404 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 23.00.In the medium term, the stock price is expected to trend up.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
CareDx Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
9
analysts
Buy
Current Rating
23.000
Target Price
+21.69%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
CareDx Inc Highlights
StrengthsRisks
CareDx, Inc. is a precision medicine solutions company. The Company is focused on the discovery, development, and commercialization of clinically differentiated healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the provider of genomics-based information for transplant patients. Its commercially available post-transplant testing services consist of AlloSure Kidney, a donor-derived cell-free DNA, or dd-cfDNA, solution for kidney transplant patients, AlloMap Heart, a gene expression profiling solution for heart transplant patients, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Its lab product portfolio includes QTYPE, Olerup SSP and SBT, AlloSeq Tx, AlloSeq HCT, and AlloSeq cfDNA. It also offers a diverse portfolio of digital solutions to transplant centers.
Turnaround to Profit
The company's performance has turned profitable, with the latest annual net income of USD .
Overvalued
The company’s latest PE is 14.42, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 52.64M shares, increasing 0.08% quarter-over-quarter.
Held by PRFDX
Star Investor PRFDX holds 14.98K shares of this stock.
CareDx Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
CareDx Inc Info
CareDx, Inc. is a precision medicine solutions company. The Company is focused on the discovery, development, and commercialization of clinically differentiated healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the provider of genomics-based information for transplant patients. Its commercially available post-transplant testing services consist of AlloSure Kidney, a donor-derived cell-free DNA, or dd-cfDNA, solution for kidney transplant patients, AlloMap Heart, a gene expression profiling solution for heart transplant patients, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Its lab product portfolio includes QTYPE, Olerup SSP and SBT, AlloSeq Tx, AlloSeq HCT, and AlloSeq cfDNA. It also offers a diverse portfolio of digital solutions to transplant centers.
Ticker SymbolCDNA
CompanyCareDx Inc
CEOHanna (John W)
Websitehttps://www.caredx.com/
FAQs
What is the current price of CareDx Inc (CDNA)?
The current price of CareDx Inc (CDNA) is 19.450.
What is the symbol of CareDx Inc?
The ticker symbol of CareDx Inc is CDNA.
What is the 52-week high of CareDx Inc?
The 52-week high of CareDx Inc is 25.950.
What is the 52-week low of CareDx Inc?
The 52-week low of CareDx Inc is 10.960.
What is the market capitalization of CareDx Inc?
The market capitalization of CareDx Inc is 999.87M.
What is the net income of CareDx Inc?
The net income of CareDx Inc is 52.55M.
Is CareDx Inc (CDNA) currently rated as Buy, Hold, or Sell?
According to analysts, CareDx Inc (CDNA) has an overall rating of Buy, with a price target of 23.000.
What is the Earnings Per Share (EPS TTM) of CareDx Inc (CDNA)?
The Earnings Per Share (EPS TTM) of CareDx Inc (CDNA) is 1.349.
Related Instruments
+1.32%
-0.88%
+1.75%
+0.83%
+0.60%
+0.38%
+0.91%
+1.03%
+2.32%
+0.60%
+0.40%
+1.97%
+1.63%
+1.21%
+0.65%
+0.66%
+2.57%
0.00%
-0.44%
+1.06%
